Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Subscribe To Our Newsletter & Stay Updated